| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.8 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.8 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.8 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.8 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.8 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.8 |